NCT02500511View on ClinicalTrials.gov

Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

September 30, 2015

Conditions
Meningococcal MeningitisMeningococcal Infections
Interventions
BIOLOGICAL

NmVac4-A/C/Y/W-135-DT™

no intervention in this study, received test vaccine in trial JN-NM-002

Trial Locations (1)

21204

IRC Clinics, Towson

Sponsors
All Listed Sponsors
lead

JN-International Medical Corporation

INDUSTRY